Literature DB >> 10995035

Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.

T Watanabe1, N Shinohara, K Moriya, A Sazawa, Y Kobayashi, Y Ogiso, M Takiguchi, J Yasuda, T Koyanagi, N Kuzumaki, A Hashimoto.   

Abstract

The epidermal growth factor (EGF) receptor has been suggested to have an important role in tumor initiation and progression of human bladder cancers. Grb2 protein, which is the downstream effector of the EGF receptor, acts as an adaptor protein between the EGF receptor and the Ras guanine-nucleotide exchange factor, son of sevenless (Sos) protein. Sos protein regulates the action of Ras protein by promoting the exchange of GDP for GTP. However, the significance of Grb2 and Sos proteins, which is related to EGF-triggered Ras activation, has not been elucidated in human bladder cancer. The aim of the present study is to clarify the significance of these proteins in human bladder cancer cell lines. In the present study, we used four human bladder cancer cell lines (T24, KU-7, UMUC-2, UMUC-6) and two kinds of cultured normal urothelial cells (HMKU-1, HMKU-2) isolated from patients with no malignancy. We examined the expression of EGF receptor, Grb2, and Sos proteins in these cells by Western blot analysis. Furthermore, the bladder cancer cell lines were subjected to sequence analysis to identify a point mutation in the c-H-ras gene at codon 12. There was no marked difference in the expression of the EGF receptor between human bladder cancer cell lines and cultured normal urothelial cells. On the other hand, expression of Grb2 and Sos proteins was substantially increased in all human bladder cancer cell lines examined in comparison with cultured normal urothelial cells, whether codon 12 of H-ras was mutated or not. These results suggest that the amplification of both Grb2 and SOS proteins plays an important role in the carcinogenesis of human bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995035     DOI: 10.1080/15216540050033195

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  11 in total

1.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

2.  Allosteric regulation of GRB2 modulates RAS activation.

Authors:  Neda S Kazemein Jasemi; Mohammad R Ahmadian
Journal:  Small GTPases       Date:  2022-01

3.  Evaluation of NF1 and RASA1 gene expression in endometriosis.

Authors:  Ghafour Yarahmadi; Mehran Dehghanian; Reyhaneh Sadat Sandoghsaz; Mohamadreza Savaee; Farimah Shamsi; Mohammad Yahya Vahidi Mehrjardi
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2022-05-04

Review 4.  Grb2 signaling in cell motility and cancer.

Authors:  Alessio Giubellino; Terrence R Burke; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

5.  Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Li-Yan Li; En-Min Li; Zhi-Yong Wu; Hui-Hui Cao; Jin-Hui Shen; Xiu-E Xu; Bo Chen; Jian-Yi Wu; Li-Yan Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

6.  EGF receptor uses SOS1 to drive constitutive activation of NFκB in cancer cells.

Authors:  Sarmishtha De; Josephine Kam Tai Dermawan; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

7.  miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.

Authors:  Chaojie Liang; Yingchen Xu; Hua Ge; Bingchen Xing; Guanqun Li; Guangming Li; Jixiang Wu
Journal:  Oncotarget       Date:  2017-11-18

8.  USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma.

Authors:  Hong-Beom Park; Sohyun Hwang; Kwang-Hyun Baek
Journal:  Cell Death Dis       Date:  2022-08-10       Impact factor: 9.685

9.  The Grb2 splice variant, Grb3-3, is a negative regulator of RAS activation.

Authors:  Caroline Seiler; Amy K Stainthorp; Sophie Ketchen; Christopher M Jones; Kate Marks; Philip Quirke; John E Ladbury
Journal:  Commun Biol       Date:  2022-09-28

10.  Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Authors:  Agnieszka Latosinska; Marika Mokou; Manousos Makridakis; William Mullen; Jerome Zoidakis; Vasiliki Lygirou; Maria Frantzi; Ioannis Katafigiotis; Konstantinos Stravodimos; Marie C Hupe; Maciej Dobrzynski; Walter Kolch; Axel S Merseburger; Harald Mischak; Maria G Roubelakis; Antonia Vlahou
Journal:  Oncotarget       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.